SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

News > Suppliers

Read more breaking news

 

 

Asia takes guts, but Australia’s complementary landscape has your back

By RJ Whitehead , 26-Aug-2014
Last updated on 26-Aug-2014 at 16:35 GMT2014-08-26T16:35:00Z

Asia takes guts, but Australia’s complementary landscape has your back

With Australia's domestic market maturing, many complementary health companies are seeing the growth that some of the big brands are enjoying in Asia and are keen to ride in on their coat tails. 

This is according to Ian Chant, managing director of TSI Pharmaceutical, a multinational Australian company that supplies and packages an extensive range of non-scheduled, complementary, listed and registered products. 

Through TSI’s experience in overseas markets, and as a result of Chant’s role as a board member of Complementary Medicines Australia, for whom he works on industry development and export initiatives for the Australian companies, the company is in a good position to advise its customers on how to realise their Asian ambitions. 

It pays to be wary, but give it a go

When we talk to them about opportunities, and we know a little bit about these markets. As a result, they become quite excited,” he told FoodNavigator-Asia from Brisbane.

In this industry, Australians are very internally focused, and they don’t realise the assets they have in terms of safety and the regulatory environment — all the pluses the Australian manufacturing environment gives them.” 

Daunted by the vagaries of the Asian markets, Chant says, many Australian companies tend to put their plans on hold after some initial research. But once they see their competitors enjoying success overseas, they come back to TSI for more advice. 

They start saying, ‘gee, it’s not a bad idea after all’. They have to understand the markets to some extent, and some of these markets can be segmented, so the opportunities are definitely there for companies to go into just one part of the market, and not necessarily all of it

Understanding the market presents a tremendous advantage, though a lot of brand owners at the moment don’t recognise or understand fully what it on their doorstep.”

Demand for Down Under medicines

Chant says that Chinese consumers are calling out for Westernised medicines—something that can be seen at Australian duty free shops, for instance, where Chinese often pick up healthcare products as gifts on the way back home. 

There are a number of brands in China that are westernised, like Amway. I do believe there is a positive attitude towards Westernised medicine, however the regulations in Asia have perhaps not kept pace with the changing consumer demand

We’re starting to see right now the Chinese health authorities starting to review the regulatory framework. I’m not saying it’s necessarily going to deliver a great windfall for Westernised medicines, but there is a consideration about it. And I believe the concept of medical foods is also being developed in China.”

Chant says it is the uncertainty, more than the cost of gaining regulatory approval, that is holding Australian companies back from Asian expansion.

We don’t know if their regulations sill be in place in 12 months’ time. I don’t think anybody has problems paying the price, as long as that’s going to be the framework for a longer period

There has been a reasonable amount of change and the government is consolidating the regulation of these medicines into a central agency. But it has caused some interpretation issues and more uncertainty for exporters

I think people are still excited about opportunities in China, and remember that China is only one market—there are many more interesting places to do good business, like in Indonesia and Thailand.” 

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Fytexia
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Indena
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Capsugel
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Ingredion
Balancing Innovation and Risk in Sports Nutrition Ingredients
NSF-International
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Roquette
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars